Blincyto and Disease recurrence - a phase IV clinical study of FDA data

Summary:

Disease recurrence is reported as a side effect among people who take Blincyto (blinatumomab), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Januvia, and have B precursor type acute leukaemia.

The phase IV clinical study analyzes which people have Disease recurrence when taking Blincyto. It is created by eHealthMe based on reports of 6,058 people who have side effects when taking Blincyto from the FDA, and is updated regularly.

What is Blincyto?

Blincyto has active ingredients of blinatumomab. eHealthMe is studying from 6,058 Blincyto users. Check the latest studies of Blincyto.

What is Disease recurrence?

Disease recurrence is found to be associated with 1,242 drugs and 1,552 conditions by eHealthMe. Check the latest studies of Disease recurrence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

6,058 people reported to have side effects when taking Blincyto.
Among them, 58 people (0.96%) have Disease recurrence.

Could Blincyto cause Disease recurrence?

Among these 58 people:

How long have people been on Blincyto when they have Disease recurrence? *

What is the gender of people who have Disease recurrence when taking Blincyto? *

female: 34.38 %
male: 65.62 %

What is the age of people who have Disease recurrence when taking Blincyto? *

What are other drugs people take besides Blincyto? *

Tacrolimus: 1 person, 1.72%
Sprycel: 1 person, 1.72%
Benadryl: 1 person, 1.72%
Besponsa: 1 person, 1.72%
Colace: 1 person, 1.72%
Diflucan: 1 person, 1.72%
Glivec: 1 person, 1.72%
Hydrocodone Bitartrate And Acetaminophen: 1 person, 1.72%
Iclusig: 1 person, 1.72%
Januvia: 1 person, 1.72%

What are other side effects people have besides Disease recurrence? *

Death: 9 people, 15.52%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 5.17%
Drug Ineffective: 3 people, 5.17%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 5.17%
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 2 people, 3.45%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 3.45%
Infection: 2 people, 3.45%
Confusional State: 2 people, 3.45%
Blast Cell Count Increased: 2 people, 3.45%
Fever: 2 people, 3.45%

What are the existing conditions these people have? *

B Precursor Type Acute Leukaemia (lymphoid cancer): 3 people, 5.17%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 3.45%
Precursor B-Lymphoblastic Lymphoma (precursor b-cell cancer): 1 person, 1.72%
Pain: 1 person, 1.72%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 1.72%

* Approximation only. Some reports may have incomplete information.

Do you take Blincyto and have Disease recurrence?

- Check whether Disease recurrence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Blincyto:

Blincyto (6,058 reports)

Browse all side effects of Blincyto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease recurrence:

Disease recurrence (1,242 drugs)

Browse all the conditions that are associated with Disease recurrence:

Disease recurrence (1,552 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on blinatumomab (the active ingredients of Blincyto) and Blincyto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.